IRIS
LEONE, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.415
AS - Asia 2.190
EU - Europa 1.768
SA - Sud America 501
AF - Africa 81
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.328
SG - Singapore 964
CN - Cina 552
BR - Brasile 437
IT - Italia 373
SE - Svezia 329
RU - Federazione Russa 305
HK - Hong Kong 299
DE - Germania 250
VN - Vietnam 157
GB - Regno Unito 119
FR - Francia 86
FI - Finlandia 81
CA - Canada 52
ID - Indonesia 44
IN - India 43
UA - Ucraina 43
BE - Belgio 34
PL - Polonia 27
AR - Argentina 26
ES - Italia 24
ZA - Sudafrica 23
MX - Messico 22
CI - Costa d'Avorio 21
CZ - Repubblica Ceca 20
IQ - Iraq 20
BD - Bangladesh 18
AT - Austria 17
TR - Turchia 17
JP - Giappone 15
NL - Olanda 13
EC - Ecuador 10
IE - Irlanda 10
LT - Lituania 10
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
CO - Colombia 7
MA - Marocco 7
VE - Venezuela 7
EG - Egitto 6
AU - Australia 5
CH - Svizzera 5
KE - Kenya 5
NP - Nepal 5
PE - Perù 5
SA - Arabia Saudita 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
UZ - Uzbekistan 5
LB - Libano 4
PY - Paraguay 4
AZ - Azerbaigian 3
HR - Croazia 3
JM - Giamaica 3
OM - Oman 3
RS - Serbia 3
BH - Bahrain 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
MT - Malta 2
NO - Norvegia 2
PA - Panama 2
TN - Tunisia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GT - Guatemala 1
HT - Haiti 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
MY - Malesia 1
PS - Palestinian Territory 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
UY - Uruguay 1
Totale 9.959
Salva come PNG Salva come JPEG
Città #
Ashburn 668
Chandler 528
Singapore 517
Fairfield 503
Woodbridge 396
Hong Kong 297
Nyköping 275
Houston 245
Beijing 236
Seattle 227
Cambridge 219
Ann Arbor 215
New York 200
Wilmington 186
Bari 131
Jacksonville 103
Los Angeles 100
Dallas 85
Lawrence 84
Roxbury 83
Munich 78
Brooklyn 56
Nanjing 55
Santa Clara 51
Buffalo 49
Des Moines 49
Ho Chi Minh City 48
Inglewood 40
Jakarta 38
São Paulo 36
Hanoi 35
Brussels 34
Chicago 34
London 33
Moscow 31
Princeton 28
Rome 28
Helsinki 24
Washington 24
Boardman 23
San Diego 23
Marseille 22
Abidjan 21
Dong Ket 21
Toronto 21
Redwood City 20
Johannesburg 19
Turku 19
Council Bluffs 18
Denver 18
Nanchang 18
San Jose 18
Warsaw 18
Paris 17
Salt Lake City 16
Stockholm 16
Columbus 15
Frankfurt am Main 15
Montreal 15
Santa Marinella 15
Shenyang 15
The Dalles 15
Tokyo 15
Brno 14
Falkenstein 14
Rio de Janeiro 14
Grafing 13
Jiaxing 13
Leawood 13
Orem 13
Salvador 13
Boston 12
Chennai 12
Belo Horizonte 11
Hebei 11
Dublin 10
Elk Grove Village 10
Guangzhou 10
Phoenix 10
Triggiano 10
Ankara 9
Baghdad 9
Dearborn 9
Indianapolis 9
Manchester 9
Mexico City 9
San Francisco 9
Vienna 9
Augusta 8
Milan 8
Nuremberg 8
Pune 8
Tampa 8
Tianjin 8
Atlanta 7
Brasília 7
Changsha 7
Sannicandro di Bari 7
Amsterdam 6
Biên Hòa 6
Totale 6.865
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 274
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 218
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 205
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 200
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 188
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 172
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 171
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 166
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 165
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 163
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 161
A spatial view of the CD8(+) T-cell response: the case of HCV 157
Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery 155
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 155
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 155
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 155
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 152
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 151
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 146
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 141
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 140
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 139
Giant cell arteritis: The experience of two collaborative referral centers and an overview of disease pathogenesis and therapeutic advancements 137
Bortezomib treatment modulates autophagy in multiple myeloma 128
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 124
Flogosis and heart involvement in large vessel vasculitis 122
Cancer treatment and the KIR–HLA system: an overview 120
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 120
In vitro proliferation of naive B cells and memory B cells: different profiles from healthy and HCV-infected individuals 119
Common variable immunodeficiency and gastric malignancies 119
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 118
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 118
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 115
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 113
Bone marrow of persistently hepatitis C virus-infected individuals accumulates memory CD8+ T cells specific for current and historical viral antigens: A study in patients with benign hematological disorders 112
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 111
Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements 111
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 110
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 109
Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances 109
Actors on the scene: Immune cells in the myeloma niche 109
Vasculitis in connective tissue diseases 107
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 106
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 105
Carcinogenesis and Metastasis in Liver: Cell Physiological Basis 104
Alternative splicing of HLA-C mRNA in HCV-infected hepatocytes reduces viral epitope-specific cytotoxicity T cell response and promotes NK activity 103
Antibody production and in vitro behavior of CD27-defined B cell subsets: persistent HCV infection changes the rules 102
Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules 101
The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3) 100
Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery 99
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 99
Bone marrow endothelial cells: a red light for T cell responses against multiple myeloma 91
1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia 88
When something goes wrong: B cell responses to hepatitis C virus 88
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 87
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 86
Echocardiographic alteration in patients with systemic lupus erythematosus affected by hepatic steatosis: a cross-sectional single center study 79
CANCER STEM CELLS IN MULTIPLE MYELOMA AND THE DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES 77
Lupus vasculitis: An overview 77
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 76
Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma 74
Mucine-1 is related to cell-mediated immunoexpression and blood pressure in pulmonary artery in pulmonary arterial hypertension (PAH): Preliminary results 73
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 72
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 72
CD8 T cell regulation by bone marrow endothelial cells in multiple myeloma. 69
Flogosis and Heart involvement in Large Vessel Vasculitis 69
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 68
Proteasome subunit composition in dendritic cells and hepatocytes of HCV-infected subjects 66
null 61
Role of the microRNA-29b in multiple myeloma progression 60
Interplay between bone marrow endothelial cells and CD8 T cells in multiple myeloma. 60
Endothelial cells in tumor microenvironment: insights and perspectives 59
Bone marrow endothelial cells of patients with multiple myeloma: antigen presenting functions and T cell regulation 59
Pancreatic cancer signaling pathways, genetic alterations, and tumor microenvironment: The barriers affecting the method of treatment 58
Chirurgia vascolare 57
Endothelial cells from bone marrow of patients with multiple myeloma: antigen presenting functions and T cell regulation 57
null 57
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 57
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 57
Junctional adhesion molecule-A as a prognostic factor and new therapeutic target in multiple myeloma. 56
The “angiogenic switch” from MGUS to MM: what about the Notch role? 56
Adipose failure through adipocyte overload and autoimmunity 53
Memory B cell analysis in patients with persistent HCV infection 53
Dendritic cells are recruited to the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T cell killing. 53
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 53
Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review) 52
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 51
Long-term follow up of patients with acute hepatitis C and spontaneous resolution 50
Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche 48
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 46
The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters 46
Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report 45
null 44
Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study 43
The major antigenic determinant of CENP-A shows antigenic and immunogenic homology with the transcription factor forkhead box E3 (FOXE3). Serendipity or functional significance? 43
Increased frequency and suppressive function of T regulatory cells in Multiple Myeloma 42
Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells 41
null 41
Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma 40
The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study 38
Totale 9.927
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021669 0 0 0 0 0 103 76 113 79 140 73 85
2021/2022786 55 65 21 28 41 48 27 58 53 39 123 228
2022/20231.344 155 196 123 113 106 184 26 165 206 11 39 20
2023/2024656 37 88 39 32 57 262 30 24 7 8 11 61
2024/20252.232 77 42 166 89 89 189 288 214 63 134 384 497
2025/20262.334 652 221 219 432 591 219 0 0 0 0 0 0
Totale 10.488